SynthesisPloS one2024

The relative risk of immune checkpoint inhibitor pneumonitis in advanced non-small- cell lung cancer: Meta-analyses of controlled clinical trials.

Ying Kong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.